Print Page  Close Window
Meridian Bioscience Hires Vice President of Sales and Marketing

CINCINNATI--(BUSINESS WIRE)--Jan. 12, 2004--Meridian Bioscience, Inc., (Nasdaq:VIVO) today announced that Gregory S. Ballish has joined Meridian Bioscience, Inc. as Vice President Sales and Marketing. Ballish joins Meridian as a pharmaceutical and diagnostics industry veteran, having spent the last five years in senior sales management and strategic customer marketing roles with Janssen Pharmaceutica (Johnson & Johnson subsidiary). Mr. Ballish has also held positions of national sales and marketing responsibility for Ortho Clinical Diagnostics (J&J) and had been responsible for launching several key products and leading them to a position of market strength. Earlier in his career, Mr. Ballish held senior sales and marketing roles with DuPont and Abbott Laboratories.

Mr. Ballish holds a Master of Business Administration degree from Arizona State University and a Bachelor of Science in Finance from Miami University.

As Vice President, Mr. Ballish will provide strategic leadership to Meridian's sales and marketing organization and will further expand Meridian's position as a market leader in innovative products that are designed to enhance patient well-being while reducing total costs of healthcare.

John A Kraeutler, President and Chief Operating Officer stated, "I am delighted to welcome Greg to Meridian's senior management team. Greg has a broad background in developing and leading sales and marketing teams within the pharmaceutical and diagnostics industries. His focus on strong relationships and innovative marketing approaches will provide Meridian with important leadership in clinical diagnostics and life science."

Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, urinary and respiratory infections. All Meridian diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents and specialty biologicals along with proteins and other biologicals used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices and diagnostics manufacturers in more than 60 countries around the world. The Company's shares are traded through Nasdaq's National Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.

CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, 513-271-3700

SOURCE: Meridian Bioscience, Inc.